Acute phase glycoproteins: bystanders or participants in carcinogenesis?

Annals of the New York Academy of Sciences
Eugene Dempsey, Pauline M Rudd

Abstract

Acute phase proteins (APPs) are a group of serum proteins that undergo dramatic changes in concentration during times of inflammation. Many APPs are heavily glycosylated, and their sugar content and complexity change in the presence of cancer-induced chronic inflammation. These changes in glycosylation are currently being exploited in the search for novel biomarkers of cancer. Like other posttranslational modifications, such as phosphorylation, changes in glycosylation can profoundly alter the function of a protein. We hypothesize that besides being a rich source of potential biomarkers APPs may also play an active role in tumorigenesis. The glycan content of the APPs haptoglobin and kininogen, for example, is altered in many types of cancer. These APPs can interact with a number of receptors on macrophages in the tumor microenvironment, potentially modulating macrophage activity and thereby contributing to tumor cell survival, growth, and metastasis.

References

Mar 1, 1971·The Journal of Surgical Research·E F FarkouhL D MacLean
Oct 1, 1994·The Journal of Experimental Medicine·E FattoriV Poli
Feb 11, 1999·The New England Journal of Medicine·C Gabay, I Kushner
Nov 30, 1999·Journal of Leukocyte Biology·M M Van den HeuvelR H Beelen
Dec 22, 1999·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·R WebsterS G Jezequel
Dec 2, 2000·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·J C ZhangK R McCrae
Jan 4, 2001·Atherosclerosis·J S Millar
Feb 24, 2001·Nature·M KristiansenS K Moestrup
Sep 1, 2001·Biochimie·A Harduin-LepersP Delannoy
Jul 16, 2002·Laboratory Investigation; a Journal of Technical Methods and Pathology·Izumi HayashiMasataka Majima
Dec 20, 2002·International Immunopharmacology·Irma Isordia-SalasRobert W Colman
May 23, 2003·Journal of Cellular Biochemistry·Yan-Lin GuoRobert W Colman
Jun 15, 2004·Clinica Chimica Acta; International Journal of Clinical Chemistry·H Van VlierbergheJ Delanghe
Aug 10, 2004·American Journal of Clinical Pathology·S M Hossein Sadrzadeh, Jafar Bozorgmehr
May 10, 2005·Peptides·John M StewartLaimute Taraseviciene-Stewart
Oct 28, 2005·Journal of Zhejiang University. Science. B·E GruysS J Koopmans
Dec 1, 2005·The Journal of Biological Chemistry·Xiangchun WangNaoyuki Taniguchi
Dec 31, 2005·International Journal of Cancer. Journal International Du Cancer·Noriko OkuyamaEiji Miyoshi
Jan 21, 2006·Cancer Research·Claire E Lewis, Jeffrey W Pollard
Oct 18, 2006·The Journal of Biological Chemistry·Yanyang ZhaoJianguo Gu
May 9, 2007·Proceedings of the National Academy of Sciences of the United States of America·Falk NimmerjahnJeffrey V Ravetch
Sep 7, 2007·International Journal of Cancer. Journal International Du Cancer·Tsutomu FujimuraSen-itiroh Hakomori
Jan 25, 2008·International Journal of Cancer. Journal International Du Cancer·Miyako NakanoEiji Miyoshi
Jan 26, 2008·Journal of Biochemistry·Eiji MiyoshiTsutomu Nakagawa

❮ Previous
Next ❯

Citations

Nov 14, 2012·Molecular & Cellular Proteomics : MCP·Thibault ChazeOlivier Guipaud
Feb 1, 2013·Molecular & Cellular Proteomics : MCP·L Renee RuhaakCarlito B Lebrilla
Feb 18, 2016·Cancer Medicine·Saiko KazunoTsutomu Fujimura
Jan 18, 2015·Clinica Chimica Acta; International Journal of Clinical Chemistry·Meritxell BalmañaRosa Peracaula
Nov 14, 2015·Journal of Proteomics·Meritxell BalmañaRosa Peracaula
Nov 10, 2015·Clinica Chimica Acta; International Journal of Clinical Chemistry·Margery A ConnellyRobin P F Dullaart
Mar 10, 2016·Biochimica Et Biophysica Acta·Juan Etxebarria, Niels-Christian Reichardt
Dec 5, 2015·Scientific Reports·Brian A AguadoLonnie D Shea
Mar 25, 2014·Autoimmunity Reviews·Radjiv GoulabchandPhilippe Guilpain
Jun 18, 2016·Clinica Chimica Acta; International Journal of Clinical Chemistry·Margery A ConnellyRobin P F Dullaart
Aug 24, 2018·Clinical Chemistry and Laboratory Medicine : CCLM·Mengmeng WangChunfang Gao
Oct 12, 2016·Scientific Reports·Andreas J HülsmeierThierry Hennet
Jul 15, 2020·Molecular Aspects of Medicine·Alessandra di MasiPaolo Ascenzi
Sep 30, 2014·Journal of Proteome Research·Petr PompachRadoslav Goldman
Nov 22, 2019·Journal of Proteome Research·Olga O ZaytsevaMislav Novokmet

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Related Papers

Breast Cancer Research : BCR
Aurélie CazetPhilippe Delannoy
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications
Pablo Guardado-CalvoMark J van Raaij
© 2022 Meta ULC. All rights reserved